These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26177447)

  • 1. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
    Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
    Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
    Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
    Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
    Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
    Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
    Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q
    Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
    Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q
    Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
    Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
    Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
    Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
    Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
    Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
    Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis.
    Qin QP; Chen ZF; Qin JL; He XJ; Li YL; Liu YC; Huang KB; Liang H
    Eur J Med Chem; 2015 Mar; 92():302-13. PubMed ID: 25575314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
    Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
    J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor activity [correction for activitiy] of trans(+/-)-1,2-diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome.
    Han I; Kim OJ; Lee GY; Sung YK; Song R; Sohn YS
    Bioorg Med Chem; 2003 Dec; 11(24):5443-7. PubMed ID: 14642589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antitumor and antiangiogenic activity of organoplatinum(II) complexes.
    Zamora A; Pérez SA; Rodríguez V; Janiak C; Yellol GS; Ruiz J
    J Med Chem; 2015 Feb; 58(3):1320-36. PubMed ID: 25581345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR; Gerberich JL; Nowotnik DP; Howell SB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
    Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
    Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light.
    Ramu V; Gautam S; Garai A; Kondaiah P; Chakravarty AR
    Inorg Chem; 2018 Feb; 57(4):1717-1726. PubMed ID: 29400953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.